TriVascular, Inc.
Endologix is a global medical device company dedicated to delivering healthcare innovation to improve the lives of patients with vascular disease. Guided by data, they pioneer interventions that address unmet needs in vascular conditions, empowering physicians with innovative therapies and immersive training programs. Their mission emphasizes disruptive innovation, clinical evidence, and tailored solutions for complex anatomies, especially in the treatment of abdominal aortic aneurysms and peripheral artery disease.
Industries
Nr. of Employees
large (251-1000)
TriVascular, Inc.
2 Musick, Irvine, CA 92618, U.S.A.
Patents
Products
Abdominal stent graft with adaptive sealing
Endovascular abdominal stent graft system with an adaptive sealing element designed to conform to irregular aortic neck anatomy. Indicated for infrarenal abdominal aortic aneurysms when anatomical criteria are met (examples of common criteria: proximal landing/seal zone beginning ~7 mm below the inferior renal artery; inner aortic diameter range commonly specified in labeling; conicity and thrombus/calcification thresholds used to assess suitability).
Bifurcated unibody endograft with anatomically fixed sealing
Unibody bifurcated endograft designed to preserve native bifurcation and separate fixation from sealing zones; labeling specifies anatomic sizing requirements such as minimum aortic neck length, diameter ranges and overlap requirements for extension components.
Percutaneous transmural arterial bypass system for femoropopliteal lesions
Percutaneous system and associated implantation technique that create a femoropopliteal bypass routed through the femoral vein under fluoroscopic guidance to revascularize long or complex femoropopliteal occlusions. Labeling and legal information specify lesion length and occlusion ranges for indicated use and list anatomy- and risk-based contraindications.
Abdominal stent graft with adaptive sealing
Endovascular abdominal stent graft system with an adaptive sealing element designed to conform to irregular aortic neck anatomy. Indicated for infrarenal abdominal aortic aneurysms when anatomical criteria are met (examples of common criteria: proximal landing/seal zone beginning ~7 mm below the inferior renal artery; inner aortic diameter range commonly specified in labeling; conicity and thrombus/calcification thresholds used to assess suitability).
Bifurcated unibody endograft with anatomically fixed sealing
Unibody bifurcated endograft designed to preserve native bifurcation and separate fixation from sealing zones; labeling specifies anatomic sizing requirements such as minimum aortic neck length, diameter ranges and overlap requirements for extension components.
Percutaneous transmural arterial bypass system for femoropopliteal lesions
Percutaneous system and associated implantation technique that create a femoropopliteal bypass routed through the femoral vein under fluoroscopic guidance to revascularize long or complex femoropopliteal occlusions. Labeling and legal information specify lesion length and occlusion ranges for indicated use and list anatomy- and risk-based contraindications.
Services
Provision of virtual reality–based procedural training programs and clinician education to support adoption and proficiency with endovascular therapies.
Coding guides, payer resources and a reimbursement support center to assist providers in navigating payment programs and obtaining coverage for qualifying device procedures.
Sponsorship and operational support for investigator-initiated and sponsor-led clinical trials, randomized controlled trials, and post-market studies to generate evidence for vascular devices.
Online library of procedural animations, brochures, webinars, podcasts, case reviews and clinical data summaries to support clinician education and patient information needs.
Provision of virtual reality–based procedural training programs and clinician education to support adoption and proficiency with endovascular therapies.
Coding guides, payer resources and a reimbursement support center to assist providers in navigating payment programs and obtaining coverage for qualifying device procedures.
Sponsorship and operational support for investigator-initiated and sponsor-led clinical trials, randomized controlled trials, and post-market studies to generate evidence for vascular devices.
Online library of procedural animations, brochures, webinars, podcasts, case reviews and clinical data summaries to support clinician education and patient information needs.
Expertise Areas
- Endovascular aneurysm repair (EVAR) device design
- Percutaneous transmural arterial bypass (PTAB) therapies for complex femoropopliteal disease
- Clinical trial management and post‑market evidence generation
- Anatomic suitability assessment and IFU specification for vascular devices
Key Technologies
- Adaptive sealing elements for stent grafts
- Low-profile endovascular delivery systems
- Unibody/bifurcated endograft architectures
- Helical nitinol stent frameworks
News & Updates
Announcement of Scott Huennekens joining the Board of Directors.
FDA approval for the DETOUR System to treat complex PAD lesions.
Lucas Buchanan joins the Board of Directors.
First treatments using the DETOUR System for complex PAD.
Positive 24-month results from the DETOUR-2 trial.
Graham Phillips appointed COO to oversee manufacturing, supply chain, R&D, and quality.
Announcement of Scott Huennekens joining the Board of Directors.
FDA approval for the DETOUR System to treat complex PAD lesions.
Lucas Buchanan joins the Board of Directors.
First treatments using the DETOUR System for complex PAD.
Positive 24-month results from the DETOUR-2 trial.
Graham Phillips appointed COO to oversee manufacturing, supply chain, R&D, and quality.